Polypeptide with electroactive endgroups as sensing platform for the abused drug 'methamphetamine' by bioelectrochemical method
dc.contributor.author | Demir, Bilal | |
dc.contributor.author | Yilmaz, Tulay | |
dc.contributor.author | Guler, Emine | |
dc.contributor.author | Gumus, Z. Pinar | |
dc.contributor.author | Akbulut, Huseyin | |
dc.contributor.author | Aldemir, Ebru | |
dc.contributor.author | Coskunol, Hakan | |
dc.contributor.author | Colak, Demet Goen | |
dc.contributor.author | Cianga, Ioan | |
dc.contributor.author | Yamada, Shuhei | |
dc.contributor.author | Timur, Suna | |
dc.contributor.author | Endo, Takeshi | |
dc.contributor.author | Yagci, Yusuf | |
dc.date.accessioned | 2019-10-27T11:24:17Z | |
dc.date.available | 2019-10-27T11:24:17Z | |
dc.date.issued | 2016 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Affinity-type sensors have emerged as outstanding platforms in the detection of diagnostic protein markers, nucleic acids and drugs. Thus, these novel platforms containing antibodies could be integrated into the monitoring systems for abused drugs. Herein, we established a novel detection platform for the analysis of a common illicit drug; methamphetamine (METH). Initially, a fluorescent-labeled polypeptide (EDOT-BTDA-Pala), derived from L-alanine N-carboxyanhydride (L-Ala-NCA) via ring-opening polymerization using 4,7-bis(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)benzo[c][1,2,5]thiadiazole-5,6-diamine (EDOT-NH2-BTDA) as initiator, was employed as a glassy carbon electrode (GCE) covering host, in order to immobilize the METH selective antibody. Prior to the examination of analytical features, GCE/EDOT-BTDA-Pala/Antibody surface was successfully characterized in the way of electrochemical (cyclic voltammetry and electrochemical impedance spectroscopy) and microscopic techniques (scanning electron microscopy and fluorescence microscopy). As for the analytical characterization, linearity and limit of detection (LOD) were found as 10-100 mu g/mL with an equation of y=0.0429x-0.2347, (R-2=0.996) and 13.07 mu g/mL, respectively. Moreover, sample application using artificial urine, saliva and serum samples spiked with METH (10, 25, 50 mu g/mL) were performed and LC-MS/MS system was used for further confirmation. The described platform can be adapted to monitor the other types of abused drugs by using suitably selected biorecognition elements. | en_US |
dc.description.sponsorship | Industrial Thesis Support Program (SAN-TEZ) of Republic of TurkeyMinistry of Science, Industry & Technology - Turkey; Ministry of Science, Industry and Technology [0620.STZ.2014]; Republic of Turkey, Ministry of DevelopmentTurkiye Cumhuriyeti Kalkinma Bakanligi [2016K121190]; Ege University Research Fund through BAP project [16-FEN-004]; Istanbul Technical University Research Fund; TUBITAKTurkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) | en_US |
dc.description.sponsorship | This work was supported by Industrial Thesis Support Program (SAN-TEZ) of Republic of Turkey, Ministry of Science, Industry and Technology (Project Grant No: 0620.STZ.2014) and Republic of Turkey, Ministry of Development (Project Grant No: 2016K121190). This work was also partially supported by Ege University Research Fund through BAP project (Project No: 16-FEN-004) and Istanbul Technical University Research Fund. G. Bozokalfa from Ege University is acknowledged for the technical helps. Likrom Company was acknowledged for their support to the chromatographic analyses. One of the authors (I.C) thanks to TUBITAK for the financial support by means of "Fellowships For Visiting Scientists and Scientists On Sabbatical Leave" programme. | en_US |
dc.identifier.doi | 10.1016/j.talanta.2016.09.042 | en_US |
dc.identifier.endpage | 796 | en_US |
dc.identifier.issn | 0039-9140 | |
dc.identifier.issn | 1873-3573 | |
dc.identifier.pmid | 27769482 | en_US |
dc.identifier.startpage | 789 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.talanta.2016.09.042 | |
dc.identifier.uri | https://hdl.handle.net/11454/33261 | |
dc.identifier.volume | 161 | en_US |
dc.identifier.wos | WOS:000386989500104 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | Talanta | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Polypeptide | en_US |
dc.subject | Surface modification | en_US |
dc.subject | Abused drug analysis | en_US |
dc.subject | Methamphetamine | en_US |
dc.subject | Immunosensor | en_US |
dc.subject | Chromatography | en_US |
dc.title | Polypeptide with electroactive endgroups as sensing platform for the abused drug 'methamphetamine' by bioelectrochemical method | en_US |
dc.type | Article | en_US |